Over the last week of October, we participated in BioEurope 2020. Although the event went digital this year, we really enjoyed a productive week of meetings with partners and collaborators. We are excited to see such interest in our approach and looking forward to progress our discussions and support drug discovery programs with our unique AI approach.
top of page
Recent PostsSee All
Combination Accelerates Outcomes in Early Drug Discovery WALTHAM, Mass.; Oct. 28, 2021 – X-Chem, the pioneer of DNA-encoded library (DEL) technology and a recognized leader in generating actionable re
We participated in BioTrinity 2021. This is the first in-person meeting we are attending this year, we are very much looking forward for many to come. Our CEO, Noor Shaker, presented our recent progre
London-based GlamorousAI Secures Grant From Innovate UK to Fund a £440k Project toward Development of New Treatments For Glioblastoma Multiforme. GlamorousAI, a leading artificial intelligence biotech
bottom of page